Treatment Outcomes of Treatment-Naïve Hepatitis C Patients Co-Infected with HIV: A Systematic Review and Meta-Analysis of Observational Cohorts

Optimizing Hepatitis C Therapy in HIV/hepatitis C Virus (HCV) Coinfected Patients: Analysis of HCV Viral Kinetics on Treatment

(2016) Paul Damien James et al.   Canadian Journal of Infectious Diseases & Medical Microbiology

Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis

(2014) Nathan Ford et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Relationship of Liver Disease Stage and Antiviral Therapy With Liver-Related Events and Death in Adults Coinfected With HIV/HCV

(2012) Berkeley N. Limketkai et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Circulating sCD14 Is Associated with Virological Response to Pegylated-Interferon-Alpha/Ribavirin Treatment in HIV/HCV Co-Infected Patients

(2012) Giulia Marchetti et al.   PLoS One

Influence of IL28B Polymorphisms on Response to a Lower-Than-Standard Dose peg-IFN-α 2a for Genotype 3 Chronic Hepatitis C in HIV-Coinfected Patients

(2012) Luis F. López-Cortés et al.   PLoS One

Treatment of Hepatitis C as Prevention: A Modeling Case Study in Vietnam

(2012) Nicolas Durier et al.   PLoS One

HCV RNA decline in the first 24h exhibits high negative predictive value of sustained virologic response in HIV/HCV genotype 1 co-infected patients treated with peginterferon and ribavirin

(2011) N. Laufer et al.   ANTIVIRAL RESEARCH

Considerable under-treatment of chronic HCV infection in HIV patients despite acceptable sustained virological response rates in a real-life setting

(2011) Thomas Reiberger et al.   ANTIVIRAL THERAPY

High uptake of hepatitis C virus treatment in HIV/hepatitis C virus co-infected patients attending an integrated HIV/hepatitis C virus clinic

(2011) J Kieran et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus

(2011) J. Berenguer et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load

(2011) Karin Neukam et al.   JOURNAL OF HEPATOLOGY

Ability of treatment week 12 viral response to predict long-term outcome in genotype 1 hepatitis C virus/HIV coinfected patients

(2010) Eva Van den Eynde et al.   AIDS

The cytotoxic lymphocyte antigen 4 polymorphisms affect response to hepatitis C virus-specific therapy in HIV(+) patients with acute and chronic hepatitis C virus co-infection

(2010) Hans Dieter Nischalke et al.   AIDS

The influence of abacavir and other antiretroviral agents on virological response to HCV therapy among antiretroviral-treated HIV-infected patients

(2010) Valerianna K Amorosa et al.   ANTIVIRAL THERAPY

The basal activation state of DC subsets correlates with anti-HCV treatment outcome in HCV/HIV co-infected patients

(2010) Alessandra Sacchi et al.   CLINICAL IMMUNOLOGY

Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy

(2010) Lynn E. Taylor et al.   DRUG AND ALCOHOL DEPENDENCE

Hepatitis C virus treatment rates and outcomes in HIV/hepatitis C virus co-infected individuals at an urban HIV clinic

(2010) Melanie C.M. Murray et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirin

(2010) J. Macias et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Proteome‐Wide Anti–Hepatitis C Virus (HCV) and Anti‐HIV Antibody Profiling for Predicting and Monitoring the Response to HCV Therapy in HIV‐Coinfected Patients

(2010) Peter D. Burbelo et al.   JOURNAL OF INFECTIOUS DISEASES

Very early prediction of response to HCV treatment with PEG-IFN-alfa-2a and ribavirin in HIV/HCV-coinfected patients

(2010) E. S. A. Araújo et al.   JOURNAL OF VIRAL HEPATITIS

Equitable access to HCV care in HIV-HCV co-infection can be achieved despite barriers to health care provision

(2010) Curtis Cooper   Therapeutics and Clinical Risk Management

Similar hepatitis C virus RNA kinetics in HIV/hepatitis C virus monoinfected genotype 2 or 3 matched controls during hepatitis C virus combination therapy

(2009) Karlström Olle et al.   AIDS

Peginterferon Plus Ribavirin for Chronic Hepatitis C in Patients With Human Immunodeficiency Virus

(2009) Lise Lotte Gluud et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

A Sustained Viral Response Is Associated With Reduced Liver-Related Morbidity and Mortality in Patients With Hepatitis C Virus

(2009) Amit G. Singal et al.   Clinical Gastroenterology and Hepatology

Efficacy and Safety of Pegylated Interferon plus Ribavirin in HIV and Hepatitis C Virus–Coinfected Patients with Advanced Immunosuppression

(2009) José A. Mira et al.   CLINICAL INFECTIOUS DISEASES

Rate and Timing of Hepatitis C Virus Relapse after a Successful Course of Pegylated Interferon plus Ribavirin in HIV‐Infected and HIV‐Uninfected Patients

(2009) José Medrano et al.   CLINICAL INFECTIOUS DISEASES

Chronic hepatitis C in patients co-infected with human immunodeficiency virus in Japan: a retrospective multicenter analysis

(2009) Hiroshi Yotsuyanagi et al.   HEPATOLOGY RESEARCH

Impact of hyperglycaemia and cholesterol levels on the outcome of hepatitis C virus (HCV) treatment in HIV/HCV-coinfected patients

(2009) M Cesari et al.   HIV MEDICINE

Hepatitis C Viral Kinetics During Treatment With Peg IFN-alpha-2b in HIV/HCV Coinfected Patients as a Function of Baseline CD4+ T-Cell Counts

(2009) Neumann U Avidan et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Clinical Outcomes of Hepatitis C Treatment in a Prison Setting: Feasibility and Effectiveness for Challenging Treatment Populations

(2008) Duncan Smith‐Rohrberg Maru et al.   CLINICAL INFECTIOUS DISEASES

Therapeutical Aspects and Outcome of HIV/HCV Coinfected Patients Treated with Pegylated Interferon plus Ribavirin in an Italian Cohort

(2008) E. Righi et al.   INFECTION

The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferon

(2008) D. Aguilar Marucco et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Serum concentrations of ribavirin and pegylated interferon and viral responses in patients infected with HIV and HCV

(2008) Florence Nicot et al.   JOURNAL OF MEDICAL VIROLOGY